Results 231 to 240 of about 59,343,149 (303)

Marketing features of derived intoxicating cannabinoid product brands on Instagram: A content analysis

Addiction, EarlyView.
Abstract Background and aims Use of derived intoxicating cannabinoid products (DICPs) has grown in the United States (US), as have associated poisonings, emergency department visits and psychotic episodes. Brand marketing on social media, a largely underregulated marketing channel, may be contributing to this growth.
Kathryn La Capria, Siyan Meng, Alisa A. Padon, Kayla K. Tillett, Scott I. Donaldson, Jon‐Patrick Allem, Matthew E. Rossheim, Cassidy LoParco, Carla J. Berg, Kristina M. Jackson, Julia Chen‐Sankey   +10 more
wiley   +1 more source

Problems in comparing tobacco regulatory models and excise when only two countries are considered

Addiction, EarlyView.
Simon Chapman, Sam Egger, Becky Freeman
wiley   +1 more source

Towards the implementation of cannabis‐focused apps in early intervention services for psychosis: A qualitative investigation of patient and clinician perspectives

Addiction, EarlyView.
Abstract Background and aims Cannabis use is highly prevalent among young adults with first‐episode psychosis (FEP) and is associated with poorer clinical and functional outcomes. Mobile health interventions may help address structural barriers to delivering cannabis‐focused psychosocial interventions within early intervention services (EIS), yet ...
Selim Abou‐Rahal, Alexis Doucet, Pamela Lachance‐Touchette, Amal Abdel‐Baki, Stephanie Coronado‐Montoya, José Côté, Ovidiu Tatar, Philip G. Tibbo, Didier Jutras‐Aswad   +8 more
wiley   +1 more source

Testing the robustness of daily associations of affect with alcohol and cannabis use. [PDF]

J Psychopathol Clin Sci
Dora J, Kuczynski AM, McCabe CJ, Creswell KG, Dvorak RD, Howard AL, Patrick ME, Shoda Y, Smith GT, Wright AGC, King KM.   +10 more
europepmc   +1 more source

Joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in substance use disorder: Longitudinal evidence from the All of Us research program

Addiction, EarlyView.
Abstract Background and aims Recovery capital and genetic liability may be related to substance use disorder (SUD) remission through psychosocial and biologic pathways, but their joint association with remission course remains poorly understood. This question is clinically important because people entering remission differ in recovery resources and ...
Janaka V. Kosgolla, Douglas C. Smith
wiley   +1 more source

Stigma toward individuals with cannabis use disorder across age groups: associations with familiarity and sociodemographic characteristics. [PDF]

Harm Reduct J
Basedow LA, Wandinger E, Brindle A, Kölch M, Reis O.   +4 more
europepmc   +1 more source

On 3‐MMC: A Cathinone I Have Come to Know and Love

Anthropology of Consciousness, EarlyView.
ABSTRACT This article attempts to complicate the mythology of a compound in a state of becoming. I will trace lightly its origins as a cultural disruptor and how I am implicated in this imperative. Introducing you to 3‐MMC will require multiple modes of storytelling and taking of liberties, drawing on literature reviews, practice‐based research, prose,
Carmen Ostrander
wiley   +1 more source

A Scoping Systematic Review of Cannabis Use in Endometriosis. [PDF]

Aust N Z J Obstet Gynaecol
McLaren K, Erridge S, Sodergren MH.
europepmc   +1 more source

Sudden Unexpected Death in Infancy in New Zealand: A Review of Coronial Recommendations

Acta Paediatrica, EarlyView.
ABSTRACT Aims Sudden Unexpected Death in Infancy (SUDI) remains a leading cause of post‐neonatal mortality in Aotearoa New Zealand. We analysed New Zealand coronial findings and recommendations to identify recurring modifiable risks, social determinants of health, and system‐level failures that might inform prevention strategies.
Edwin A. Mitchell, Stephanie F. Cowan, Barry J. Taylor   +2 more
wiley   +1 more source

Associations between neighborhood disadvantage, cannabis use, and patient-reported outcomes among patients with cancer. [PDF]

Drug Alcohol Depend Rep
Greene B, Ghosh S, Colder C, Meghani S, Worster B, Ashare R.   +5 more
europepmc   +1 more source